Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$253.3 - $285.89 $36,981 - $41,739
146 Added 19.97%
877 $225,000
Q2 2023

Jul 18, 2023

SELL
$275.25 - $318.06 $10,734 - $12,404
-39 Reduced 5.06%
731 $208,000
Q1 2023

Apr 27, 2023

SELL
$256.56 - $292.34 $35,405 - $40,342
-138 Reduced 15.2%
770 $214,000
Q4 2022

Jan 19, 2023

BUY
$252.44 - $306.72 $229,215 - $278,501
908 New
908 $0
Q2 2022

Jul 22, 2022

BUY
$187.54 - $223.02 $12,940 - $15,388
69 Added 5.95%
1,229 $251,000
Q1 2022

Apr 26, 2022

SELL
$193.77 - $244.14 $191,638 - $241,454
-989 Reduced 46.02%
1,160 $244,000
Q4 2021

Jan 14, 2022

BUY
$223.92 - $287.77 $34,259 - $44,028
153 Added 7.67%
2,149 $516,000
Q3 2021

Oct 19, 2021

BUY
$282.99 - $369.05 $48,674 - $63,476
172 Added 9.43%
1,996 $565,000
Q2 2021

Jul 19, 2021

BUY
$259.0 - $414.71 $111,111 - $177,910
429 Added 30.75%
1,824 $632,000
Q1 2021

Apr 27, 2021

BUY
$242.95 - $284.63 $21,865 - $25,616
90 Added 6.9%
1,395 $390,000
Q4 2020

Jan 29, 2021

BUY
$236.26 - $355.63 $99,701 - $150,075
422 Added 47.79%
1,305 $320,000
Q3 2020

Oct 29, 2020

SELL
$264.77 - $305.71 $145,888 - $168,446
-551 Reduced 38.42%
883 $250,000
Q2 2020

Jul 28, 2020

BUY
$258.66 - $342.55 $370,918 - $491,216
1,434 New
1,434 $384,000
Q4 2019

Jan 29, 2020

SELL
$220.06 - $304.07 $328,989 - $454,584
-1,495 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $42,618 - $47,800
196 Added 15.09%
1,495 $348,000
Q2 2019

Aug 06, 2019

BUY
$219.29 - $241.72 $65,787 - $72,516
300 Added 30.03%
1,299 $304,000
Q1 2019

May 07, 2019

SELL
$216.71 - $338.96 $180,736 - $282,692
-834 Reduced 45.5%
999 $236,000
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $510,490 - $646,590
1,833 New
1,833 $552,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Stratos Wealth Advisors, LLC Portfolio

Follow Stratos Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.